Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/1995
03/07/1995CA1334646C Transdermal penetration enhancers
03/04/1995CA2131430A1 Microsomal triglyceride transfer protein
03/04/1995CA2131255A1 Tocopherols
03/04/1995CA2117656A1 Naphthoxazines
03/04/1995CA2105528A1 Heparin component for the treatment of neutrophil elastase-mediated damages, in particular associated with cystic fibrosis
03/03/1995CA2712821A1 Use of oxidase inhibitor with dextromethorphan to treat intractable coughing and dermatitis
03/03/1995CA2131074A1 Therapeutic or preventive agents for diseases associates with peroxylipid
03/02/1995WO1995006068A1 Novel polysaccharide and radioprotective agent containing the same as active ingredient
03/02/1995WO1995006054A1 Compound uch9
03/02/1995WO1995006047A1 Antimicrobial quinolinyl-(1h-1,2,4-triazol-1-yl)alkanol derivatives
03/02/1995WO1995006046A1 Indole derivatives as thromboxane a2 antagonists
03/02/1995WO1995006045A1 α-PYRONE COMPOUND
03/02/1995WO1995006044A1 Amide and urea derivatives as 5ht1d receptor antagonists
03/02/1995WO1995006040A1 Benzodiazepine compounds useful as antagonists of cck or of gastrine
03/02/1995WO1995006038A1 Platelet aggregation inhibitors
03/02/1995WO1995006035A1 Benzazepine derivative, pharmaceutical composition containing the same, and intermediate for the same
03/02/1995WO1995006034A1 Compounds and methods for inhibition of hiv and related viruses
03/02/1995WO1995006031A1 Inhibitors of tnf-alpha secretion
03/02/1995WO1995006020A1 New diphenylhexene
03/02/1995WO1995005853A1 Method, compositions and devices for administration of naked polynucleotides which encode biologically active peptides
03/02/1995WO1995005852A1 Agent against sensitive, hyperreactive and hypoactive states of the skin, forms of acne, atopic dermatitides, psoriasis, prurigo, photodermatoses, ichthyosis and viral infections
03/02/1995WO1995005835A1 Gene therapy for solid tumors, papillomas and warts
03/02/1995WO1995005834A1 Use of 2-deoxycoformycin (pentostatin) for treating cerebral and cardiovascular disorders
03/02/1995WO1995005833A1 Pharmaceutical composition for immunoenhancement therapy
03/02/1995WO1995005831A1 Pharmaceutical compositions containing morphine-6-glucuronide for the treatment of pain
03/02/1995WO1995005830A1 Polyanion anti-inflammatory agents
03/02/1995WO1995005829A1 Therapeutic system for treating psoriasis
03/02/1995WO1995005828A1 Progesterone-antagonistic and anti-oestrogen compounds for the therapy of leiomyomata uteri
03/02/1995WO1995005827A1 Agent for transdermal application containing gestoden esters
03/02/1995WO1995005826A1 Method for regulating neuropeptide hormone secretion
03/02/1995WO1995005825A1 Circulatory disturbance ameliorant
03/02/1995WO1995005823A1 Use of n-alkylated 1,4-dihydropyridine dicarboxylic acid esters as medicaments
03/02/1995WO1995005822A1 Inhibition of smooth muscle cell migration by (r)-amlodipine
03/02/1995WO1995005821A1 Di- and tetra-hydrobenzo[f]quinolin-3-ones
03/02/1995WO1995005820A1 Novel use of dexmedetomidine
03/02/1995WO1995005819A1 Methods for treating circadian rhythm phase disturbances
03/02/1995WO1995005818A1 Photosensitizers
03/02/1995WO1995005817A1 Novel 1,2-dithiin antiinfective agents
03/02/1995WO1995005816A1 Sodium cromoglycate for the treatment of upper respiratory tract infections
03/02/1995WO1995005815A1 Iontophoretic delivery of an antimigraine drug
03/02/1995WO1995005814A1 Pharmaceutical compositions comprising metal complexes
03/02/1995WO1995005813A1 COMPOSITIONS AND METHODS FOR THE ADMINISTRATION OF δ-AMINOLEVULINIC ACID
03/02/1995WO1995005811A1 Method of inhibiting nitric oxide formation
03/02/1995WO1995005810A1 Compositions and methods for the detection and treatment of protein trafficking disorders and increasing secretory protein production
03/02/1995WO1995005807A1 A novel pharmaceutical for oral administration comprising progesterone and a polyethylene glycol together with an excipient
03/02/1995WO1995005805A1 Process for conditioning substances
03/02/1995WO1995003303A3 Aza spiro compounds acting on the cholinergic system with muscarinic agonist activity
03/02/1995WO1994028726A3 Method of treating retained pulmonary secretions
03/02/1995WO1994025601A3 New sequences of hepatitis c virus genotypes and their use as therapeutic and diagnostic agents
03/02/1995WO1994025025A3 Systems for controlled release of pilocarpine
03/02/1995DE4425481A1 Melanoma-inhibiting protein
03/02/1995DE4406261A1 Composition for reducing the amount of body fat
03/02/1995DE4328965A1 Novel diphenylhexenes
03/02/1995CA2170504A1 Compositions and methods for the administration of u-aminolevulinic acid
03/02/1995CA2170373A1 Benzazepine derivative, pharmaceutical composition thereof, and intermediate thereof
03/02/1995CA2170371A1 Agent for transdermal administration that contains gestodene esters
03/02/1995CA2170285A1 Use of n-alkylated 1,4-dihydropyridine dicarboxylic acid esters as medicaments
03/02/1995CA2170279A1 Indole derivatives as thromboxane a2 antagonists
03/02/1995CA2170253A1 Pharmaceutical compositions comprising metal complexes
03/02/1995CA2170158A1 Inhibitors of tnf-alpha secretion
03/02/1995CA2170140A1 Novel 1,2-dithiin antiinfective agents
03/02/1995CA2170031A1 Antimicrobial quinolinyl-(1h-1,2,4-triazol-1-yl)alkanol derivatives
03/02/1995CA2169840A1 A novel pharmaceutical for oral administration comprising progesterone and a polyethylene glycol together with an excipient
03/02/1995CA2169750A1 Di- and tetra-hydrobenzo[f]quinolin-3-ones
03/02/1995CA2169210A1 Compositions and methods for the detection and treatment of protein trafficking disorders and increasing secretory protein production
03/02/1995CA2169089A1 Benzodiazepine derivatives
03/02/1995CA2168882A1 Therapeutic system for treating psoriasis
03/02/1995CA2168449A1 Iontophoretic delivery of an antimigraine drug
03/02/1995CA2168345A1 Phenylamidine derivatives as platelet aggregation inhibitors
03/02/1995CA2147762A1 Circulatory disorder improving agent
03/02/1995CA2147612A1 Compound uch9
03/02/1995CA2130891A1 Shoulder support-type of firewood carrier having built-in multiple handles and a hooking component
03/01/1995EP0640829A2 Scanning probe microscope
03/01/1995EP0640688A1 Ribozymes
03/01/1995EP0640619A1 Erythropoietin analogs with additional glycosylation sites
03/01/1995EP0640617A1 Substituted azepino (2,1-a)isoquinoline compounds
03/01/1995EP0640616A2 17-Alkylcarbonate, 21-0-carbonic/carboxylic acid esters of corticosteroids, a method for their production and pharmaceutical compositions containing them
03/01/1995EP0640615A1 Chelators, their preparation from the antibiotics salmycins A, B, C or D and their use
03/01/1995EP0640614A2 Stereoselective process for preparing beta-anomer enriched 2-deoxy-2, 2-difluoro-d-ribofuranosyl-3, 5-hydroxy protected-1-alkyl and aryl sulfonate intermediates
03/01/1995EP0640613A1 OLIGOSIALYL-1,2-DIALKYL-Sn-GLYCEROL AND INTERMEDIATE FOR ITS SYNTHESIS
03/01/1995EP0640612A1 Novel derivatives from 2-(1H)-quinolinone, process for their preparation and pharmaceutical compositions containing them
03/01/1995EP0640609A1 Fused phenol derivatives having inhibitory activity on TXA2 synthetase, and 5-lipoxygenase and scavenging activity on oxygen species
03/01/1995EP0640607A1 2-Beta-alkenyl-penem-sulfonyl compounds as beta-lacterase inhibitors
03/01/1995EP0640606A1 Thienopyrimidine derivatives, their production and use
03/01/1995EP0640602A1 Benzo[b]furancarboxamide derivatives, process for their preparation and their use as gastrointestinal mobility-enhancing agents
03/01/1995EP0640599A1 4-Aminopyrimidine derivatives
03/01/1995EP0640596A1 N-pyridazinyl-benzene (naphthalene-, biphenyl-) sulfonamide derivatives, their preparation and their use as endothelin antagonists
03/01/1995EP0640593A1 Substituted benzoylguanidines, process for their preparation, their use as medicine or in diagnostic and medicines containing them
03/01/1995EP0640592A1 N-acylated tricyclic azaheterorings useful as vasopressin antagonists
03/01/1995EP0640590A1 Process for the synthesis of 4-mercaptophenols and naphthalenols
03/01/1995EP0640588A1 Orthosubstituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic agent and a medicament containing them
03/01/1995EP0640587A1 Diacyl substituted guanidins, process for their preparation, their use as medicament or diagnostic reagent and medicament containing them
03/01/1995EP0640581A1 Endermic nutrient material and cosmetic composition containing the same
03/01/1995EP0640352A1 Preparation of a skin surface for a surgical procedure
03/01/1995EP0640350A2 Ceramic particles and their preparation
03/01/1995EP0640346A1 Uses of sulphated sugars against inflammation
03/01/1995EP0640345A2 Composition for inhibiting transmission of AIDS, containing silver salts with a detergent
03/01/1995EP0640344A1 Pharmaceutical composition in liquid dosage form containing ursodeoxycholic acid
03/01/1995EP0640343A1 Contraceptive for oral use containing oestradial valerate and cyproterone acetate
03/01/1995EP0640342A2 Pentoxifylline and/or depogen for improving the tissue antioxidant status
1 ... 7038 7039 7040 7041 7042 7043 7044 7045 7046 7047 7048 7049 7050 7051 7052 7053 7054 7055 7056 7057 7058 ... 7860